A study revealed that the administration of intravenous iron therapy led to a considerable decrease in NT-proBNP (N-terminal pro-B-type natriuretic peptide) levels and inflammatory status among anaemic patients with congestive heart failure and moderate chronic renal failure [12]. Here, NPPB is linked to chronic kidney disease.